Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Overview of attention for article published in Cochrane database of systematic reviews, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs: 3 blogs
twitter: 46 X users

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 175 Mendeley

Summary Blogs X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

[144] ADHD in adults

Therapeutics Initiative, 30 Sep 2023

Vignette: Your 23-year-old male primary care patient went to a walk-in clinic after watching a TikTok video about ADHD. He was…

ADHD: evidence to help you decide how best to manage the condition

Evidently Cochrane, 08 Jun 2023

In this blog for anyone affected by ADHD, Robert Walton, a GP and Senior Fellow in General Practice at Cochrane UK, examines…

Systematic Review | Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

SPECIALTIES, 22 Jul 2022

Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults – Cochrane…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.